BDM burgundy diamond mines limited

BDM 10:21 AM BioDiem completes recruitment of patients for...

  1. 374 Posts.
    lightbulb Created with Sketch. 3
    BDM 10:21 AM BioDiem completes recruitment of patients for clinical trial
    http://www.asx.com.au/asxpdf/20070430/pdf/3125py0kj04v57.pdf

    BioDiem completes recruitment of patients for its clinical trial in
    diabetic eye disease
    Australian biopharmaceutical development company BioDiem Ltd (ASX:BDM)
    announced today it has completed recruitment of 192 patients in a phase I/II clinical trial of its peptide BDM-E in patients with diabetic macula oedema, a leading cause of blindness.

    Commenting on this milestone today, BioDiem Chief Executive Officer, Tom Williams said, “It’s pleasing to have completed this significant step in executing the clinical trial. We now expect to report on the result of the trial during Q4, CY 2007.”
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
2.2¢
Change
-0.001(4.35%)
Mkt cap ! $31.26M
Open High Low Value Volume
2.2¢ 2.2¢ 2.2¢ $1K 45.45K

Buyers (Bids)

No. Vol. Price($)
6 489140 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.4¢ 383415 3
View Market Depth
Last trade - 15.36pm 12/09/2025 (20 minute delay) ?
BDM (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.